Related Experiment Video
Updated: May 7, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Superficial Vein Thrombosis: A Review
Gregory Piazza1,2, Darsiya Krishnathasan1,2, Nada Hamade1,2
1Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Superficial vein thrombosis (SuVT) affects superficial veins and can progress to deep vein thrombosis. Treatment involves anticoagulation for extensive or symptomatic cases, especially near deep veins.
Area of Science:
- Vascular Medicine
- Thrombosis Research
- Medical Diagnostics
Background:
- Superficial vein thrombosis (SuVT) involves thrombus formation in superficial veins, with an annual incidence of 64-131 per 100,000 person-years.
- A significant percentage (10%) of SuVT patients may progress to deep vein thrombosis (DVT) or pulmonary embolism (PE).
- Risk factors include endothelial injury, venous stasis, and hypercoagulability, with higher incidence in females.
Purpose of the Study:
- To outline the pathophysiology and clinical presentation of superficial vein thrombosis.
- To review diagnostic approaches and management strategies for SuVT.
- To highlight the importance of differentiating and treating SuVT, particularly concerning its proximity to deep veins.
Main Methods:
- Review of existing literature on superficial vein thrombosis.
- Analysis of clinical risk factors, diagnostic methods (including ultrasonography and D-dimer testing), and treatment outcomes.
- Comparison of management strategies based on SuVT length and location relative to deep veins.
Main Results:
- SuVT incidence is higher in females and often presents as a tender, palpable cord.
- D-dimer testing shows limited sensitivity for excluding SuVT.
- Approximately 25% of lower extremity SuVT cases have concomitant DVT.
- Ultrasonography is crucial for confirming SuVT presence and extent.
Conclusions:
- Superficial vein thrombosis requires careful management, with anticoagulation indicated for extensive or high-risk cases.
- Treatment decisions are guided by SuVT length, symptoms, and proximity to deep venous structures.
- Prompt and appropriate treatment can mitigate the risk of progression to more severe venous thromboembolic events.
Related Concept Videos
Atherosclerosis I: Introduction
Peripheral Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Venous Thrombosis I: Introduction
Ischemic Stroke l: Introduction
Transient Ischemic Attack l: Introduction

